Robert Half Inc. (RHI)

NYSE: RHI · USD

$41.9

-0.06 (-0.1%)· Recorded snapshot

영어 원본으로 대체KO

번역하는 동안 영어 원본을 표시 중

이 리포트는 아직 번역되지 않았습니다. 번역 대기열이 따라잡으면 몇 분 후에 새로고침하세요.

StockMarketAgent Research · Analyzed 2026-10-17

Our latest published analysis: RHI rated Reduce

Robert Half Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$28.3 / share

Potential value

$32.8 / share

Upside to FV

-15.2%

from $41.9

Moat

6/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$3.4B
Revenue (ttm)	5.3B
Net income (ttm)	121.7M
EPS (ttm)	$1.22
Shares out	100.6M
P/E (trailing)	34.4x
P/E (forward)	16.7x
Dividend	$2.36 (5.66%)
Volume	1,212,567
Beta	0.83

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.3B
Net income (ttm): 121.7M
EPS (ttm): $1.22
P/E (trailing): 34.4x
P/E (forward): 16.7x
Market cap: $3.4B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$6.46B	$7.24B	$6.39B	$5.80B	$5.38B	-4.5%
Gross profit	$2.70B	$3.09B	$2.58B	$2.25B	$2.00B	-7.2%
Operating income	$805.8M	$890.6M	$464.6M	$241.5M	$76.5M	-44.5%
Net income	$598.6M	$657.9M	$411.1M	$251.6M	$133.0M	-31.3%
EPS (diluted)	$5.36	$6.03	$3.88	$2.44	$1.33	-29.4%
EBITDA	$797.0M	$1.05B	$467.5M	$447.0M	$276.0M	-23.3%
R&D	—	—	—	—	—	—
SG&A	$1.95B	$2.12B	$2.11B	$2.01B	$1.93B	-0.3%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	매도
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	비중 축소
ACN	Accenture plc	144.3B	18.0x	2.0x	27.9%	+8.0%	+0.4%	보유
AAL	American Airlines Group Inc.	8.3B	—	0.1x	3.0%	+20.0%	-6.9%	보유
ADP	Automatic Data Processing, Inc.	113B	25.3x	5.1x	62.8%	+7.7%	+4.5%	보유
ALLE	Allegion plc	15.2B	22.5x	3.5x	19.4%	+8.8%	+7.2%	보유

Base and Bull scenarios

Base55%

Price target

$28.25

-15.2% from spot

In the modal base scenario, revenue stabilizes in FY2026 at $5.31B and expands to $5.53B in FY2027. Operating margins recover from the 1.42% FY2025 trough to 2.50% in FY2026 and 4.50% in FY2027, supported by $45M in annualized cost savings. Diluted EPS reaches $1.26 in FY2026 and $1.97 in FY2027. Intrinsic fair value centers at $28.25.

FY2026 revenue of $5.31B (-1.27%) and FY2027 revenue of $5.53B (+4.14%)
Consolidated operating margin recovers from cyclical trough levels in FY2025 through staged expansion in FY2026 and FY2027 toward mid-cycle profitability by FY2030
Consensus EPS tracks $1.26 in FY2026 and $1.97 in FY2027
Terminal P/E multiple of 15.0x, terminal growth rate of 2.0%, and discount rate based on moderate Ke of 8.7305%

Bull20%

Price target

$32.84

-1.4% from spot

In the bull scenario, enterprise clients unfreeze deferred finance, accounting, and IT transformation projects. Talent Solutions volume expands rapidly, while Protiviti delivers record revenues in technology consulting and non-financial services practices. Operating leverage on the rationalized cost structure drives EBIT margins toward historical high-single-digit levels over the forecast horizon.

Consolidated revenue growth accelerates to mid-to-high single digits annually over FY2027 through FY2029
Operating margin reaches 8.5% by FY2030, supported by mix shift toward higher-level placements
Protiviti revenue rebounds to low double-digit growth as technology consulting and banking advisory expand

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($28.25). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	1.5%	1.8%	2.0%	2.3%	2.5%
7.7%	$29.9	$30.5	$31.0	$31.6	$32.3
8.2%	$28.6	$29.1	$29.5	$30.0	$30.6
8.7%	$27.5	$27.9	$28.3	$28.7	$29.1
9.2%	$26.5	$26.8	$27.1	$27.5	$27.9
9.7%	$25.6	$25.9	$26.1	$26.4	$26.8

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.7

P25 n/aP50 n/aP75 n/a

Trailing P/E29

P25 n/aP50 n/aP75 n/a

ROE9.1

P25 n/aP50 n/aP75 n/a

ROIC4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All RHI indicators

Market & fundamental data

Available fields

268

Groups with data

Currency

USD

Showing 268 of 268 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000315213
Company name	Robert Half Inc.
Country	United States
Country code	US
CUSIP number	770323103
Earnings date	2026-10-22
Earnings time	amc
Employees	14,500
Employees change	-200
Employees growth	-1.36%
Enterprise value	$4.1B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-09
Fiscal year end	December
Founded	1948
Industry	Staffing & Employment Services
Is primary listing	Yes
Is SPAC	No
ISIN number	US7703231032
Last 10-K release date	2026-02-13
Last earnings date	2026-10-22
Last refreshed	2026-10-28
Last stock split date	2000-06-13
Last stock split type	Forward
Market cap	$4.2B
Market cap category	Mid-Cap
Next earnings date	2027-01-28
Options	Yes
Price	$41.90
Price currency	USD
Sector	Industrials
SIC code	7363
Stock price date	2026-10-28
Symbol	RHI
U.S. state	California
Website	https://www.roberthalf.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	34.63x
Average P/E ratio (10Y)	19.76x
Average P/E ratio (3Y)	23.99x
Average P/E ratio (5Y)	20.42x
Earnings yield	2.91%
EV/Earnings	33.75x
EV/EBIT	57.13x
EV/EBITDA	33.6x
EV/FCF	19.1x
EV/Sales	0.78x
FCF / EV yield	5.23%
FCF yield	5.13%
Forward EV/Sales	0.75x
Forward P/E	23.06x
Forward P/S	0.77x
Graham number	18.15078
Graham upside	-56.44%
Industry forward P/E	15.71x
Lynch fair value	$6.10
Lynch upside	-85.36%
P/(FCF - SBC) ratio	25.71x
P/(OCF - SBC) ratio	20.52x
P/B ratio	3.5x
P/E ratio	34.35x
P/FCF ratio	19.49x
P/OCF ratio	16.36x
P/S ratio	0.79x
Price / tangible book value	4.39x
Price/EBITDA ratio	34.29x
Sector forward P/E	26.24x
Sector P/E	40.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.36%
EBITDA margin	2.31%
Effective tax rate	37.13%
FCF margin	4.06%
Gross margin	37.29%
Operating margin	1.36%
Pretax margin	3.65%
Profit margin	2.3%
Profit per employee	$8,395
Profitable quarters	93
Profitable years	35
Revenue per employee	$365,394
ROA	0.23%
ROA (5Y)	10.8%
ROCE	0.76%
ROE	9.11%
ROE (5Y)	28.79%
ROIC	4.02%
ROIC (5Y)	34.44%
SBC / revenue	0.98%
Tax / revenue	1.36%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-20.78%
EPS growth (Q)	14.06%
EPS growth (QoQ)	88.46%
EPS growth 10Y	-7.88%
EPS growth 3Y	-34.9%
EPS growth 5Y	-23.57%
EPS growth years	0
FCF growth	-24.47%
FCF growth 3Y	-31.98%
FCF growth 5Y	-10.61%
Gross profit growth	-3.58%
Gross profit growth (Q)	5.53%
Gross profit growth 3Y	-10%
Gross profit growth 5Y	-4.34%
Net income growth	-21.73%
Net income growth (Q)	16.2%
Net income growth (QoQ)	89.49%
Net income growth 3Y	-36.32%
Net income growth 5Y	-25.35%
Net income growth years	0
OCF growth	-25.6%
OCF growth 10Y	-4.8%
OCF growth 3Y	-29.4%
OCF growth 5Y	-8.7%
Operating income growth	-39.3%
Operating income growth (Q)	450.84%
Operating income growth 3Y	-49.88%
Operating income growth 5Y	-35.26%
Revenue growth	-2.94%
Revenue growth (Q)	0.36%
Revenue growth (QoQ)	1.72%
Revenue growth 10Y	0.02%
Revenue growth 3Y	-7.28%
Revenue growth 5Y	-2.44%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-41.2M
Depreciation and amortization	$50.4M
EBIT	$71.9M
EBITDA	$122.3M
EPS	$1.22
FCF per share	$2.14
Financing cash flow	$-266.2M
Free cash flow	$215.1M
Free cash flow minus SBC	$163.1M
Gross profit	$2B
Income taxes	$71.9M
Investing cash flow	$-42.1M
Net cash flow	$-55.8M
Net income	$121.7M
Operating cash flow minus SBC	$204.3M
Operating income	$71.9M
Revenue	$5.3B
Stock-based compensation	$52M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$12.00
Debt / EBITDA	1.97
Debt / equity	0.2
Debt / FCF	1.12
Net cash (debt)	$83.9M
Net cash / market cap	2%
Net cash growth	-32.61%
Net debt / EBITDA	-0.69
Net debt / equity	-0.07
Net debt / FCF	-0.39
Piotroski F-Score	4
Shareholders' equity	$1.2B
Tangible book value	$955.5M
Tangible book value per share	$9.50
Total cash	$324.7M
Total debt	$240.8M
WACC	8.32%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.86
Current ratio	1.47
Quick ratio	0.79
Working capital	$681.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.69%
Dividend growth	2.61%
Dividend growth (10Y)	10.62%
Dividend growth (3Y)	8.07%
Dividend growth (5Y)	9.78%
Dividend growth years	22
Dividend payment date	2026-09-15
Dividend payment years	23
Dividend payout frequency	Quarterly
Dividend per share	$2.36
Dividend yield	5.66%
Ex-dividend date	2026-08-25
FCF payout ratio	110.4%
Last dividend	$0.59
Payout ratio	193.48%
Shareholder yield	6.35%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	12.86%
10Y return CAGR	4.3%
10Y total return	52.28%
150-day SMA	$33.97
15Y price change	52.35%
15Y return CAGR	5.56%
15Y total return	125.08%
1D price change	-0.14%
1M price change	12.5%
1M total return	12.5%
1W price change	22.6%
1W total return	22.6%
1Y price change	41.59%
1Y return CAGR	53.77%
1Y total return	53.73%
20-day SMA	$36.46
200-day SMA	$32.06
20Y price change	13.05%
20Y return CAGR	3.07%
20Y total return	83.19%
3M price change	4.43%
3M total return	5.81%
3Y price change	-43.14%
3Y return CAGR	-12.71%
3Y total return	-33.49%
50-day SMA	$38.80
50-day SMA vs 200-day SMA	50over200
52-week high	$47.14
52-week high date	2026-10-23
52-week low	$21.83
52-week low date	2026-03-16
5Y price change	-62.25%
5Y return CAGR	-14.36%
5Y total return	-53.93%
6M price change	58.7%
6M total return	64.37%
All-time high	$125.77
All-time high date	2022-02-09
All-time low	$0.48
All-time low date	1986-03-06
Average true range (ATR)	$2.22
Average volume	2.1M
Beta (1Y)	0.46
Beta (2Y)	0.97
Beta (5Y)	0.83
Change from 52-week high	-11.12%
Change from 52-week low	91.94%
Change from all-time high	-67%
Change from all-time low	8,623.99%
Change from open	-1.8%
Day's gap	1.69%
Dollar volume	$50.8M
High price	$42.90
Low price	$41.30
Monthly RSI	48.51
Open price	$42.67
Position in 52-week range	37.5%
Premarket change	-1.7%
Premarket close	$41.96
Premarket price	$41.25
Previous close	$41.96
Price vs 150-day SMA	22.17%
Price vs 20-day SMA	13.83%
Price vs 200-day SMA	29.45%
Price vs 50-day SMA	6.95%
Relative volume	0.57
RSI	60.23
Sharpe ratio	0.92
Sharpe ratio (3Y)	-0.17
Sharpe ratio (5Y)	-0.29
Sortino ratio	1.77
Sortino ratio (3Y)	-0.14
Sortino ratio (5Y)	-0.29
Volume	1.2M
Weekly RSI	56.96
YTD price change	52.8%
YTD total return	62.32%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	89.7M
Float percentage	89.13%
Shares change (QoQ)	0.63%
Shares change (YoY)	-0.69%
Shares held by insiders	3.84%
Shares held by institutions	120.98%
Shares outstanding	100.6M
Short % of float	21.94%
Short % of shares	19.56%
Short ratio	10.8 days

Deeper analysis on RHI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this RHI report

What is the latest published RHI stock rating?

Robert Half Inc. is shown with Reduce in the latest published report, analyzed 2026-10-17. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RHI analysis?

The full latest published report, analyzed 2026-10-17, lives at /stocks/RHI/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for RHI?

The latest published report analyzed 2026-10-17 gives RHI a fair value of USD 28 and a potential value of USD 33. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the RHI page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-17). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

ReduceRHI · Fair value $28.3-15.2%

Read full analysis →

Robert Half Inc. (RHI)

Our latest published analysis: RHI rated Reduce

Price

Financial snapshot

Fair-value bridge

Latest news · RHI

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All RHI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on RHI

Frequently asked questions

등급 이력

Category	Score	Reading
Valuation	3.0
Management	6.5
Balance Sheet	7.0
Profitability	5.0
Revenue Growth	2.5
Risk Assessment	7.5
Competitive Moat	6.0
Earnings Quality	6.0
Capital Efficiency	2.5